Stay updated on AT2220 Safety Study in Pompe Disease Clinical Trial
Sign up to get notified when there's something new on the AT2220 Safety Study in Pompe Disease Clinical Trial page.

Latest updates to the AT2220 Safety Study in Pompe Disease Clinical Trial page
- Check6 days agoChange DetectedThe footer revision label updates from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoChange DetectedThe revision number in the footer changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study details and related content with an access-denied message.SummaryDifference18%

- Check55 days agoChange DetectedThe page revision badge updated from Revision: v3.6.5 to Revision: v3.6.6, indicating a small update to the page’s revision history without changes to the study data.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page's revision tag has been updated from v3.6.4 to v3.6.5, indicating a new build/version of the page. This change is limited to metadata and does not alter content or functionality.SummaryDifference0.1%

- Check91 days agoChange DetectedThe site revision was updated from v3.6.3 to v3.6.4, indicating a maintenance/software update to the ClinicalTrials.gov interface.SummaryDifference0.1%

Stay in the know with updates to AT2220 Safety Study in Pompe Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AT2220 Safety Study in Pompe Disease Clinical Trial page.